Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion type Assertion NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_head.
- NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion description "[Despite validation of target inhibition and the demonstration of profound in vitro synergy between AZD1480 and selumetinib, it is likely that prolonged target inhibition is required to achieve in vivo therapeutic enhancement between JAK and MEK inhibitors in the treatment of JAK-mutated ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_provenance.
- NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion evidence source_evidence_literature NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_provenance.
- NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion SIO_000772 25504635 NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_provenance.
- NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion wasDerivedFrom befree-2016 NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_provenance.
- NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_assertion wasGeneratedBy ECO_0000203 NP1248075.RABV1oy1E7urhc9czICIhicdsP0kQ7WeTBfOKx0XFaXBQ130_provenance.